Literature DB >> 9408685

Remission of transplanted melanoma--clinical course and tumour cell characterisation.

G J Elder1, P Hersey, P Branley.   

Abstract

The recipient of a cadaveric kidney was found to have donor melanoma within the graft together with metastatic spread. After cessation of immunosuppression, the kidney rejected and was removed. One month later there was both clinical and radiological evidence of remission and at autopsy 5 months later there was no histological evidence of melanoma. The outcome for recipients of other organs from the same donor was varied. Tumour cells expressed HLA class 1 antigens mismatched in the recipient and mRNA for the costimulator B7, and the cytokines GM-CSF, IL-1 alpha and beta. These characteristics may have been important in the host immunological response.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9408685

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  8 in total

Review 1.  Mechanisms of Cancer Cell Dormancy--Another Hallmark of Cancer?

Authors:  Albert C Yeh; Sridhar Ramaswamy
Journal:  Cancer Res       Date:  2015-09-09       Impact factor: 12.701

Review 2.  Interferon-gamma and cancer immunoediting.

Authors:  Gavin P Dunn; Hiroaki Ikeda; Allen T Bruce; Catherine Koebel; Ravi Uppaluri; Jack Bui; Ruby Chan; Mark Diamond; J Michael White; Kathleen C F Sheehan; Robert D Schreiber
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 3.  Donor transmitted and de novo cancer after liver transplantation.

Authors:  Rajeev Desai; James Neuberger
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

Review 4.  The delicate balance of melanoma immunotherapy.

Authors:  David E Gyorki; Margaret Callahan; Jedd D Wolchok; Charlotte E Ariyan
Journal:  Clin Transl Immunology       Date:  2013-08-09

Review 5.  Immunotherapy in the Treatment of Metastatic Melanoma: Current Knowledge and Future Directions.

Authors:  Massimo Ralli; Andrea Botticelli; Irene Claudia Visconti; Diletta Angeletti; Marco Fiore; Paolo Marchetti; Alessandro Lambiase; Marco de Vincentiis; Antonio Greco
Journal:  J Immunol Res       Date:  2020-06-28       Impact factor: 4.818

6.  Low Levels of Sox2 are required for Melanoma Tumor-Repopulating Cell Dormancy.

Authors:  Qiong Jia; Fang Yang; Wei Huang; Yao Zhang; Binghao Bao; Ke Li; Fuxiang Wei; Cunyu Zhang; Haibo Jia
Journal:  Theranostics       Date:  2019-01-01       Impact factor: 11.556

7.  Melanoma in organ transplant recipients: incidence, outcomes and management considerations.

Authors:  Faisal R Ali; John T Lear
Journal:  J Skin Cancer       Date:  2012-11-25

8.  Auto-Rejection of Renal Donor-Origin Metastatic Melanoma.

Authors:  J Scott Kriegshauser; Peter L Weidenfeld; Daniel N Wochos; James W Williams
Journal:  Radiol Case Rep       Date:  2015-12-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.